Success Metrics

Clinical Success Rate
100.0%

Based on 4 completed trials

Completion Rate
100%(4/4)
Active Trials
1(20%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
2
40%
Ph phase_2
2
40%
Ph early_phase_1
1
20%

Phase Distribution

3

Early Stage

2

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Early Phase 1First-in-human
1(20.0%)
Phase 1Safety & dosage
2(40.0%)
Phase 2Efficacy & side effects
2(40.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

4 of 4 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(4)

Detailed Status

Completed4
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Early Phase 11 (20.0%)
Phase 12 (40.0%)
Phase 22 (40.0%)

Trials by Status

active_not_recruiting120%
completed480%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingearly_phase_1

Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials

NCT06489015
completedphase_1

Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects

NCT05249374
completedphase_1

Recombinant Human Serum Albumin in Healthy Subjects

NCT05179265
completedphase_2

Phase II/III of Recombinant Human Serum Albumin

NCT05858853
completedphase_2

Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites

NCT06553456

Clinical Trials (5)

Showing 5 of 5 trials
NCT06489015Early Phase 1

Recombinant Human Serum Albumin in the Treatment of AD (Alzheimer Disease) Exploratory Clinical Trials

Active Not Recruiting
NCT05249374Phase 1

Recombinant Human Serum Albumin in Patients With Liver Cirrhosis and Ascites Subjects

Completed
NCT05179265Phase 1

Recombinant Human Serum Albumin in Healthy Subjects

Completed
NCT05858853Phase 2

Phase II/III of Recombinant Human Serum Albumin

Completed
NCT06553456Phase 2

Phase II/III Clinical Trial of Recombinant Human Serum Albumin in Cirrhotic Patients With Ascites

Completed

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5